Companies › RGEN

REPLIGEN CORP COM (RGEN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000730272 · EDGAR filings · Updated 2026-07-28

REPLIGEN CORP COM (RGEN) has reported institutional ownership of 116.0%, with 438 institutional managers holding positions valued at $7.74B per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02).

Filings this week (5)

• 2026-07-28 — Current report (8-K) filed
• 2026-07-24 — 425 filed
• 2026-07-22 — 425 filed
• 2026-07-22 — 425 filed
• 2026-07-22 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, REPLIGEN CORP COM has 438 institutional holders and institutional ownership of 116.0%.

Insider activity

Insiders reported 64 transactions (1 buys, 26 sells) across 15 reporting insiders, with a net reported value of −$15.2M.

Data flags from SEC filings

Related companies

PROTAGONIST THERAPEUTICS (PTGX) · KYMERA THERAPEUTICS (KYMR) · HALOZYME THERAPEUTICS INC (HALO) · ARROWHEAD PHARMACEUTICALS IN (ARWR) · KRYSTAL BIOTECH INC (KRYS) · COGENT BIOSCIENCES INC (COGT)